Your browser doesn't support javascript.
loading
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.
Wedemeyer, Heiner; Di Marco, Vito; Garcia-Retortillo, Montserrat; Teti, Elisabetta; Fraser, Chris; Morano Amado, Luis Enrique; Rodriguez-Tajes, Sergio; Acosta-López, Silvia; O'Loan, Joss; Milella, Michele; Buti, Maria; Guerra-Veloz, María Fernanda; Ramji, Alnoor; Fenech, Mary; Martins, Alexandra; Borgia, Sergio M; Vanstraelen, Kim; Mertens, Michael; Hernández, Cándido; Ntalla, Ioanna; Ramroth, Heribert; Milligan, Scott.
Afiliación
  • Wedemeyer H; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, OE6810, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
  • Di Marco V; University of Palermo, Piazza Marina, 61, 90133 Palermo, Italy.
  • Garcia-Retortillo M; Liver Section, Gastroenterology Department, Hospital del Mar-Parc de Salut Mar, Hospital del Mar Medical Research Institute (IMIM), C/ del Dr. Aiguader, 88, 08003 Barcelona, Spain.
  • Teti E; Tor Vergata University, Via Cracovia, 50, 00133 Rome, Italy.
  • Fraser C; Cool Aid Community Health Centre, 713 Johnson St, Victoria, BC V8W 1M8, Canada.
  • Morano Amado LE; Unit of Infectious Diseases, Álvaro Cunqueiro University Hospital, Estrada de Clara Campoamor, 341, 36312 Vigo, Spain.
  • Rodriguez-Tajes S; Liver Unit, Hospital Clinic Barcelona, IDIBAPS, CIBERehd, C. de Villarroel, 170, 08036 Barcelona, Spain.
  • Acosta-López S; Digestive Diseases, Hospital Nuestra Señora de Candelaria, Ctra. Gral. del Rosario, 145, 38010 Tenerife, Spain.
  • O'Loan J; Medeco Inala & Kombi Clinic, 55b/156 Inala Ave, Brisbane, QLD 4077, Australia.
  • Milella M; School of Medicine, University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
  • Buti M; Clinic of Infectious Diseases, University of Bari, Piazza Umberto I, 1, 70121 Bari, Italy.
  • Guerra-Veloz MF; Liver Unit, Vall d'Hebron University Hospital, and CIBEREHD del Instituto Carlos III, Barcelona, Spain.
  • Ramji A; Virgen Macarena University Hospital, Av. Dr. Fedriani, 3, 41003 Seville, Spain.
  • Fenech M; Clinical Research Fellow in Hepatology at King's College Hospital, Denmark Hill, London SE5 9RS, UK.
  • Martins A; University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
  • Borgia SM; Queensland Injectors Health Network (QuIHN), Treatment and Management Programme, 1 Hamilton Pl, Bowen Hills, Brisbane, QLD 4006, Australia.
  • Vanstraelen K; Hospital Prof. Dr. Fernando Fonseca, IC19, 2720-276 Amadora, Portugal.
  • Mertens M; Infectious Diseases, William Osler Health System, 2100 Bovaird Dr E, Brampton, ON L6R 3J7, Canada.
  • Hernández C; Gilead Sciences Europe Ltd., Stockley Park, 2 Roundwood Ave, Hayes, Uxbridge UB11 1AS, UK.
  • Ntalla I; Gilead Sciences Europe Ltd., Stockley Park, 2 Roundwood Ave, Hayes, Uxbridge UB11 1AS, UK.
  • Ramroth H; Gilead Sciences Europe Ltd., Stockley Park, 2 Roundwood Ave, Hayes, Uxbridge UB11 1AS, UK.
  • Milligan S; Gilead Sciences Europe Ltd., Stockley Park, 2 Roundwood Ave, Hayes, Uxbridge UB11 1AS, UK.
Viruses ; 14(11)2022 11 11.
Article en En | MEDLINE | ID: mdl-36423102

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C / Sofosbuvir / Trastornos Mentales Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Viruses Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C / Sofosbuvir / Trastornos Mentales Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Viruses Año: 2022 Tipo del documento: Article País de afiliación: Alemania